Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05238> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05238 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05238 label "PLX4032 [drugbank:DB05238]" assertion.
- drugbank:DB05238 seeAlso DB05238 assertion.
- drugbank:DB05238 description "PLX4032, a targeted anticancer agent, selectively inhibits the cancer-causing BRAF(V600E) gene found in subsets of different cancers, including 70% of malignant melanomas and a significant number of colorectal and thyroid tumors. Plexxikon, the company developing PLX4032, will use a new test to detect the presence of this cancer-causing gene to identify patients most likely to respond to PLX4032, enabling a personalized form of treatment." assertion.
- drugbank:DB05238 identifier "drugbank:DB05238" assertion.
- drugbank:DB05238 title "PLX4032" assertion.
- drugbank:DB05238 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05238 drugbank_vocabulary:drugbank-id "DB05238" assertion.
- drugbank:DB05238 bio2rdf_vocabulary:x-identifiers.org DB05238 assertion.
- drugbank:DB05238 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05238" assertion.
- drugbank:DB05238 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05238 bio2rdf_vocabulary:identifier "DB05238" assertion.